Skip to Content

Conagra Earnings: Prudent Execution Paves the Way for Profitability Gains; Shares Remain Undervalued

""
Securities In This Article
Conagra Brands Inc
(CAG)

Conagra CAG closed its (May-ended) fiscal 2023 book with solid results—organic net sales were in line with our $3 billion estimate and adjusted EPS of $0.62 outpaced our $0.55 forecast. However, a bland fiscal 2024 outlook of 1% organic net sales growth and $2.70-$2.75 in adjusted EPS (we had forecast 2.1% and $2.70, respectively) on softer demand expectations should leave our $46.50 fair value estimate largely unchanged. Shares still appear attractive, trading 30% below our valuation. We remain optimistic about Conagra’s long-term margin improvement prospects, with our forecast calling for 18% adjusted operating margins long-term (from 14.6% in fiscal 2023), supported by a normalized cost environment and ongoing supply chain initiatives.

In the quarter, Conagra’s organic sales grew 2.2%, as a 9.9% lift from price/mix was mostly offset by a 7.7% drop in volume (including a 0.5% adverse impact from temporary supply chain disruptions). Its adjusted gross margin swelled 216 basis points to 27% on pricing actions and productivity gains. While we believe Conagra’s strategic product innovation in fast-growing categories, such as frozen and snacks (68% of fiscal 2023 U.S. retail sales), has helped the firm improve its price elasticity relative to its historical levels, we don’t think this suggests brand strength. For one, while management noted consumers are buying fewer items to stretch dollars—prompting a slowdown across multiple categories—we don’t believe this is a pervasive phenomenon given the strong results that narrow-moat General Mills and wide-moat McCormick recently reported. Further, despite lack of details, our contention on Conagra’s inferior brand positioning is buoyed by the $345 million brand impairment charge recorded in the quarter. Lastly, we think the firm’s relative underinvestment (spending 3% of sales on marketing and research and development versus 6% for peers) will eventually pressure its market share, underpinning our no-moat rating.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Erin Lash

Sector Director
More from Author

Erin Lash, CFA, is director of consumer sector equity research for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. In addition to leading the sector team, Lash covers packaged food and household and personal care companies.

Before joining Morningstar in 2006, she spent four years as an investment analyst covering retail, transportation, and technology firms for State Farm Insurance.

Lash holds a bachelor’s degree in finance from Bradley University and a master’s degree in business administration, with concentrations in accounting and finance, from the University of Chicago Booth School of Business. She also holds the Chartered Financial Analyst® designation. She ranked second in the food and tobacco industry in The Wall Street Journal’s annual “Best on the Street” analysts survey in 2013, the last year the survey was conducted.

Sponsor Center